Psychedelic therapy for body dysmorphic disorder

Journal of Psychedelic Studies 6 (1):23-30 (2022)
  Copy   BIBTEX

Abstract

In this opinion piece we propose the investigation of psychedelic-assisted psychotherapy for the treatment of body dysmorphic disorder (BDD). BDD is a psychiatric disorder characterised by appearance-based preoccupations and accompanying compulsions. While safe and effective treatments for BDD exist, non-response and relapse rates remain high. Therefore, there is a need to investigate promising new treatment options for this highly debilitating condition. Preliminary evidence suggests safety, feasibility, and potential efficacy of psychedelic treatments in disorders that share similar psychopathological mechanisms with BDD. Drawing on this evidence, as well as on relevant qualitative reports and theoretical proposals, we argue that it would be worthwhile to conduct a phase 2a study aimed at assessing the safety and feasibility of psychedelic-assisted psychotherapy in BDD. We also offer some suggestions for how future research ought to proceed.

Other Versions

No versions found

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Compassionate use of psychedelics.Martin Šurkala & Adam Greif - 2020 - Medicine, Health Care and Philosophy 23 (3):485-496.

Analytics

Added to PP
2022-05-26

Downloads
562 (#42,599)

6 months
99 (#59,259)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Chris Letheby
University of Western Australia

References found in this work

Philosophy of Psychedelics.Chris Letheby - 2021 - Oxford, UK: Oxford University Press.
Ethics and ego dissolution: the case of psilocybin.William R. Smith & Dominic Sisti - 2021 - Journal of Medical Ethics 47 (12):807-814.

Add more references